title: Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
authors.affiliation: a Department of Medical and Surgical Sciences , University of Bologna , Bologna , Italy.
authors.forename: Mauro
authors.initials: M
authors.lastname: Bernardi
authors.affiliation: a Department of Medical and Surgical Sciences , University of Bologna , Bologna , Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Caraceni
authors.affiliation: b Hygeia Associates , Grass Valley , CA USA.
authors.forename: Roberta J
authors.initials: RJ
authors.lastname: Navickis
mesh_terms: D000418:Albumins / Q000008:administration & dosage* / Q000009:adverse effects; D001201:Ascites / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007262:Infusions, Intravenous; D008103:Liver Cirrhosis / Q000150:complications* / Q000175:diagnosis / Q000401:mortality; D015201:Meta-Analysis as Topic; D019152:Paracentesis / Q000009:adverse effects / Q000401:mortality; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000418:Albumins; D010952:Plasma Substitutes
keywords: Ascites; albumin; large-volume paracentesis; meta-analysis; morbidity; mortality; post-paracentesis circulatory dysfunction